A pilot analysis of morphometric assessment of itraconazole brands using dermoscopy and its relevance in the current scenario
Open Access
- 1 January 2018
- journal article
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 9 (6) , 426-431
Abstract
Ometric characteristics is a surrogate method to determine the same. Pellet number and size are the most important parameters in this regard. Aim: We aimed to delineate few low-cost brands, the assessed variables of which fell within the formulated criteria. Materials and Methods: In all, 22 (100 mg) formulations of ITZ were included. The pellet number was calculated manually and pellet size was determined using a dermoscope with an inbuilt measurement tool. Furthermore, size variation with respect to the innovator US Food and Drug Administration (FDA)-approved brand was determined. Results: There is a large variation in pellet number and average pellet size among different brands. Pellet number ranged from 121 to 820 and average size from 959 to 1845 μm. Few brands had dummy pellets and loose powder within the capsule. Two brands within the price range of less than Rs. 20 per capsule fulfilled the three formulated criteria: of a good pellet count, small pellet size, and low size variation. Two other brands also satisfied these criteria but were priced between Rs. 20 and 30 per capsule. The innovator US FDA-approved brand had the highest number of pellets and minimum size variation but is the costliest of all assessed brands. Limitations of the Study: We cannot comment on inter-batch variation as ours was a one-point assessment. Advanced techniques such as scanning electron microscopy and drug release profile, which would have given further useful information on pellet quality, were beyond our scope. Conclusion: There is marked variation in the assessed characteristics of ITZ formulations. These morphometric characteristics may have a significant bearing on the quality of ITZ. And thus analysis of these can help clinicians make an informed decision in choosing an ITZ formulation to achieve optimal efficacy....Keywords
This publication has 11 references indexed in Scilit:
- Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in childrenClinical and Experimental Pharmacology and Physiology, 2017
- Downstream drug product processing of itraconazole nanosuspension: Factors influencing drug particle size and dissolution from nanosuspension-layered beadsInternational Journal of Pharmaceutics, 2017
- Intracutaneous pharmacokinetics of oral antifungals and their relevance in recalcitrant cutaneous dermatophytosis: Time to revisit basicsIndian Journal of Dermatology, Venereology and Leprology, 2017
- Recurrent dermatophytosis: A rising problem in Sikkim, a Himalayan state of IndiaIndian Journal of Pathology and Microbiology, 2017
- Relapse after oral terbinafine therapy in dermatophytosis: A clinical and mycological studyIndian Journal of Dermatology, 2016
- Immunoresponses in dermatomycosesThe Journal of Dermatology, 2015
- Agglomeration of Mesoporous Silica by Melt and Steam Granulation. Part I: A Comparison Between Disordered and Ordered Mesoporous SilicaJournal of Pharmaceutical Sciences, 2013
- Soluble Itraconazole in Tablet Form Using Disordered Drug Delivery Approach: Critical Scale-up Considerations and Bio-equivalence StudiesAAPS PharmSciTech, 2013
- Generic substitution of itraconazole resulting in sub-therapeutic levels and resistanceInternational Journal of Antimicrobial Agents, 2007
- Paradoxical response to itraconazole treatment in a patient with onychomycosis caused by Microsporum gypseum.1995